PURPOSE: To study the tear film clearance in contact lens associated @entity5902 @entity1 . METHODS: Fifty-eight daily-wear soft contact lens wearers completed a questionnaire regarding a survey of their contact lens usage and subjective symptoms. They were grouped according to the size of conjunctival papillae, namely @entity11620 with no papillae, @entity13435 with papillae of less than 0.3 mm, and @entity11620 with papillae of 0.3-1.0 mm in diameter. Tear film breakup time and @entity941 clearance tests were performed. RESULTS: There was a median of 1, 2, and 3 subjective symptoms in @entity11620 , @entity13435 , and @entity11620 groups respectively (p < 0.001). @entity1 with larger papillae on their upper tarsus had more subjective symptoms such as @entity809 , discharge, limbal injection, foreign body sensation and dryness sensation (p = 0.018, 0.001, 0.004, 0.005, and 0.036 respectively). They also had shorter tear film breakup time (p = 0.05), delayed tear clearance (p = 0.002) and more @entity7499 (p < 0.001). @entity1 having delayed tear clearance test tended to have more subjective symptoms (p = 0.004) and larger papillae on upper tarsus (p = 0.002). However, neither the way the @entity1 cleaned their contact lenses nor their enzyme cleaning frequency associated with the tear @entity941 clearance (p = 0.528 and 0.394, respectively). @entity409 and @entity7499 did not correlate with the delayed tear clearance either (p = 0.111 and 0.717, respectively). CONCLUSIONS: Tear clearance in contact lens associated @entity5902 @entity1 was delayed. We proposed that delayed tear clearance might increase the protein and inflammatory mediator concentrations in the tear film and contribute to the pathogenesis or aggravate the severity of contact lens associated @entity5902 .

Delayed tear clearance in contact lens associated XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity7499 :: ('MESH:D016510', 'Disease') :: ['corneal neovascularization'] @entity809 :: ('MESH:D010292', 'Disease') :: ['burning sensation'] @entity409 :: ('MESH:D008107', 'Disease') :: ['Meibomian gland dysfunction'] @entity13435 :: ('8535', 'Gene') :: ['PC2'] @entity941 :: ('MESH:D019793', 'Chemical') :: ['fluorescein'] @entity11620 :: ('5122', 'Gene') :: ['PC1', 'PC3'] @entity5902 :: ('MESH:D003233', 'Disease') :: ['papillary conjunctivitis']
@entity5902 :: (MESH:D003233,Disease) :: ['papillary conjunctivitis']
